Clinical trial EORTC 55092
Phase IB-II, open label, multicentre feasibility study of pazopanib in combination with Paclitaxel and Carboplatin in patients with platinumrefractory/ resistant ovarian, fallopian tube or peritoneal carcinoma
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | EORTC |
| EudraCT Identifier | 2010-024077-39 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01402271 |
| Inclusion criteria | Platinium-refractory |
| Last update |